NAS
DXCM icon

Nykredit A/S’s DexCom DXCM Stock Holding History

Nykredit A/S’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.5M Buy
+141,032
New +$9.4M 0.03% 395

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nykredit A/S's DXCM Position: Q2 2026 in Review

Nykredit A/S opened a new position in DexCom (DXCM) in Q2 2026: 141,032 shares worth $9.5M. The stake represents 0.03% of the portfolio and ranks #395 among its holdings.

758 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Nykredit A/S held 141,032 shares of DexCom worth $9.5M as of Q2 2026.
  • DexCom was a new Nykredit A/S position in Q2 2026.
  • DexCom made up 0.03% of Nykredit A/S's portfolio in Q2 2026, its #395 holding.
  • 758 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.